(2-isopropylthiazol-5-yl)methanamine hydrochloride CAS:1809144-15-7

(2-isopropylthiazol-5-yl)methanamine hydrochloride is employed in various pharmaceutical applications. Its primary function lies in its ability to modulate specific biological pathways, particularly those relevant to central nervous system disorders. Researchers investigate its potential as a precursor or active ingredient in medications targeting neurological conditions such as Alzheimer's disease, Parkinson's disease, and neuropathic pain. The compound's pharmacological properties make it a subject of interest for drug development. Researchers explore its interactions with neurotransmitter systems, receptor sites, and enzymatic pathways to understand its potential therapeutic effects better. In laboratory settings, (2-IP)-TMS is utilized in biochemical assays and drug screening procedures. Its precise mechanisms of action are scrutinized to identify potential drug targets and therapeutic strategies. Additionally, it serves as a reference compound in analytical chemistry techniques, aiding in the identification and quantification of related substances. However, it's important to note that (2-isopropylthiazol-5-yl)methanamine hydrochloride is intended for research purposes only and should be handled by trained professionals in controlled laboratory environments. Its use in clinical settings or human consumption is strictly prohibited without proper authorization and regulatory approval.